The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential
Frontiers in Cardiovascular Medicine · 10.06.2026 · 13
DOI: 10.3389/fcvm.2026.1805742 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 10.06.2026. Verfasst von Yaqing Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Wenling Hospital of Wenzhou Medical University (The First People's Hospital of Wenling), Wenling, Zhejiang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular calcification is a common pathological feature driving cardiovascular morbidity and mortality. Although traditionally viewed as a passive degenerative process, current evidence demonstrates that calcification is an actively regulated, cell-driven phenomenon involving osteogenic differentiation, inflammation, and metabolic disturbances. Sortilin (encoded by SORT1 ), a multi-ligand intracellular trafficking receptor, has recently emerged as a critical molecular mediator linking metabolic risk factors—such as dyslipidemia, diabetes, hypertension, and chronic kidney disease—to pro-calcific cellular responses. In addition, sortilin also plays a versatile role by directly participating in the regulation of the phenotypic transformation of vascular smooth muscle cells and valve interstitial cells. This review provides a comprehensive synthesis of SORT1 biology in calcification-related risk states, delineates mechanistic insights into its specific roles in vascular and valve tissues, and discusses translational opportunities and challenges for targeting SORT1 in the prevention and treatment of cardiovascular calcification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Wenling Hospital of Wenzhou Medical University (The First People's Hospital of Wenling), Wenling, Zhejiang, China.
- Psychology Department, Australian National University, Canberra, ACT, Australia.
Zitieren
APA
Yao, Y., Li, S., & Wang, S. (2026). The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1805742
Vancouver
Yao Y, Li S, Wang S. The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1805742
BibTeX
@article{Yao2026,
author = {Yao, Yaqing and Li, Sijia and Wang, Shuangshuang},
title = {The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1805742}
}
EUVIMED